Bruker Corporation (BRKRP) vs Krystal Biotech, Inc. (KRYS)

A side-by-side comparison of Bruker Corporation and Krystal Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BRKRP vs KRYS

growth of $100 · dividends reinvested · last 1y
BRKRP +94.8% (+94.8%/yr)KRYS +122.9% (+122.9%/yr)KRYS compounded faster over this window
100150200250Start $1002026$195$223
BRKRP KRYS

BRKRP vs KRYS: by the numbers

  • •KRYS is the larger company ($9.59B vs $8.77B market cap).
  • •KRYS is profitable (54.82% net margin) while BRKRP runs a net loss (-2.03%).
  • •BRKRP pays a dividend (3.35% yield), while KRYS has no payments in the available dividend history.

Metrics side by side

Valuation

MetricBRKRPKRYS
P/E ratioN/A40.78
Forward P/E206.0842.78
P/S ratio2.5121.78
P/B ratio3.667.06
EV / EBITDA29.4644.89
FCF yield1.07%2.69%

Profitability

MetricBRKRPKRYS
Gross margin46.69%93.34%
Operating margin3.61%44.93%
Net margin-2.03%54.82%
ROE-2.97%17.77%
ROIC2.56%14.41%

Dividends

MetricBRKRPKRYS
Dividend yield3.35%N/A

Growth (annualized)

MetricBRKRPKRYS
Revenue CAGR (5Y)9.10%N/A
FCF CAGR (5Y)-21.33%N/A
Total return CAGR (5Y)N/A44.28%

Frequently asked

Does BRKRP or KRYS pay a bigger dividend?
BRKRP pays a dividend (3.35% yield), while KRYS has no payments in the available dividend history.
Is BRKRP or KRYS more profitable?
KRYS runs the higher net margin — BRKRP at -2.03% versus KRYS at 54.82%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.